Startups
At Mendelian, our mission is to make rare diseases our priority. We have an amazing team who have built software, which enables doctors to help patients earlier, by finding the undiagnosed.
Did you know that rare diseases are not actually rare? More rare diseases are life-threatening condition that are collectively common. In fact, 1 in 17 of us will be affected by a rare disease in our lifetime. This is comparable to common diseases such as diabetes and asthma.
Rare disease symptoms often develop gradually and in different organ systems. This means patients present to different doctors for seemingly independent reasons making these diseases difficult to diagnose.
On average, rare disease patients experience 3 misdiagnoses, visit 5 different doctors and wait over 4 years before receiving a diagnosis in the UK. In the past decade, undiagnosed rare diseases have cost the NHS in excess of £3.4 billion.
Did you know that rare diseases are not actually rare? More rare diseases are life-threatening condition that are collectively common. In fact, 1 in 17 of us will be affected by a rare disease in our lifetime. This is comparable to common diseases such as diabetes and asthma.
Rare disease symptoms often develop gradually and in different organ systems. This means patients present to different doctors for seemingly independent reasons making these diseases difficult to diagnose.
On average, rare disease patients experience 3 misdiagnoses, visit 5 different doctors and wait over 4 years before receiving a diagnosis in the UK. In the past decade, undiagnosed rare diseases have cost the NHS in excess of £3.4 billion.
Overview
Location
United Kingdom, England, London
Employees
11-50
Total raised
$2.33M
Founded date
2015
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Feb 4, 2019 | Funding round | $651.8K |
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 3, 2023 | Mendelian Receives £1.4M in Funding | Mendelian, a London, UK-based digital health company building software tools to help doctors identify rare disease patients faster and diagnose them earlier, has been awarded over £1.4m. The Artificial Intelligence in Health and Care Awards... |
| Mar 3, 2023 | Mendelian's rare disease case load AI secures £1.4 million grant award | UK-based Mendelian is preparing further trials of its AI case-finding tool for diagnosing rare diseases at scale after being awarded $1.4 million from a national health innovation grant making body. The Artificial Intelligence in Health and... |
| Dec 15, 2022 | P4SY Showcase Highlights Strength of South Yorkshire MedTech Ecosystem | On 23 November, we welcomed 10 companies from the current P4SY Accelerator Programme cohort to Sheffield’s Millennium Galleries for the P4SY Showcase & MedTech Conference, bringing together startups and domain experts from across the re... |
| Aug 7, 2022 | John’s Blog: 2020 – Let’s help startups figure it out. | This year has certainly been tough. As I write parts of the UK are into their 2nd lock down with the Prime Minister now urging UK Citizens to work from home for the next 6 months and the already slowing economic recovery likely to go into r... |
| Jul 14, 2021 | Novartis BIOME UK announces selection for the HealthHub 21 Challenge, in collaboration with KQ Labs and LifeArc | London, UK. July 14, 2021: Novartis UK has today announced the selected companies for the Novartis BIOME UK HealthHub 21 Challenge, in collaboration with KQ Labs, the data-driven health accelerator of the Francis Crick Institute, and LifeAr... |
| Feb 5, 2019 | London-based medtech startup Mendelian gets more than half a million to detect rare diseases faster | The London-based medtech startup Mendelian is on the mission to improve the lives of patients by diagnosing rare diseases faster. Recently, the startup has received an endowment of €570k from Innovate UK. The financing will be employed in d... |
| Feb 4, 2019 | UK-based Mendelian receives over €570k for its rare disease diagnostics | London-based healthtech startup Mendelian, which specialises in the diagnosis of rare diseases, has received a grant of over €570k from Innovate UK, to build solutions that will assist GPs in identifying NHS patients with rare or hard to di... |
| Tem coragem de engolir um nanorobô para nadar no seu sangue? | * Por Michel Levy Pela primeira vez na história, o especialista em cirurgia gastrointestinal Antonio de Lacy realizou uma cirurgia com telementoria através de uma rede de quinta geração (5G) de telefonia móvel. Diante de um auditório lotado... |
Reviews 0
FAQ about Mendelian
When was Mendelian founded?
Mendelian was founded in 2015.
How much funding has Mendelian raised?
Mendelian has raised $2.33M in total across 2 funding rounds.
What funding rounds has Mendelian raised?
Parsers VC lists 2 funding rounds of Mendelian, among them a funding round of $651.8K on Feb 4, 2019.
What has the press written about Mendelian?
Parsers VC has collected 9 articles mentioning Mendelian, among them “Mendelian Receives £1.4M in Funding” (Mar 3, 2023) and “Mendelian's rare disease case load AI secures £1.4 million grant award” (Mar 3, 2023).
Is Mendelian still active?
Yes, Mendelian is active; its latest activity on Parsers VC dates from Mar 3, 2023.